B17. ADVANCES IN ILD THERAPY

Safety and Efficacy of Transplantation of High Cumulative Dose Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Idiopathic Pulmonary Fibrosis and Rapid Lung Function Decline

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2640 A. Averyanov, I. Koroleva, A. Sotnikova, M. Konoplyannikov, V. Lesnyak, O. Danilevskaya, V. Baklaushev

Senolytics in Idiopathic Pulmonary Fibrosis: Preliminary Results from a First-in-Human, Open-Label, Pilot Study

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2639 A. Nambiar, J. Justice, R. Pascual, Shahrukh K Hashmi, T. Tchkonia, N. LeBrasseur, J. Kirkland, N. Musi, S. Kritchevsky

Epidemiology and Effect of Therapy in Patients with Interstitial Pneumonia with Autoimmune Features (IPAF)

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2641 Pier-Valerio Mari, S. Kay, E. Belloli, Jamie S Sheth, M. Salisbury, C. Holtze, B. Wang, J. Myers, Kristine E. Konopka, Amir Lagstein, E. Kazerooni, A. Chughtai, D. Vummidi, V. Nagaraja, D. Khanna, K. Flaherty, L. Richeldi, E. White